π£ VC round data is live. Check it out!
- Public Comps
- Mach7 Technologies
Mach7 Technologies Valuation Multiples
Discover revenue and EBITDA valuation multiples for Mach7 Technologies and similar public comparables like BIT Computer, MeVis, 111, Deepnoid and more.
Mach7 Technologies Overview
About Mach7 Technologies
Mach7 Technologies Ltd is a healthcare software company focused on enterprise imaging infrastructure. The companyβs vendor neutral platform enables health systems to manage, access, and exchange medical imaging data across departments, sites, and vendors. It serves across North America, Asia-Pacific, and the Middle East, with deployments ranging from academic medical centres to multi-site health networks. A substantial part of revenue is derived in the form of Subscription revenue. Geographically, it derives a majority of its revenue from North America.
Founded
1977
HQ

Employees
103
Website
Financials (LTM)
EV
$37M
Valuation Multiples
Start free trialMach7 Technologies Financials
Mach7 Technologies reported last 12-month revenue of $20M and negative EBITDA of ($3M).
In the same LTM period, Mach7 Technologies generated ($3M) in EBITDA losses and had net loss of ($6M).
Revenue (LTM)
Mach7 Technologies P&L
In the most recent fiscal year, Mach7 Technologies reported revenue of $16M and EBITDA of ($1M).
Mach7 Technologies is unprofitable as of last fiscal year, with gross margin of 82%, EBITDA margin of (7%), and net margin of (25%).
Financial data powered by Morningstar, Inc.
Mach7 Technologies Stock Performance
Mach7 Technologies has current market cap of $49M, and enterprise value of $37M.
Market Cap Evolution
Mach7 Technologies' stock price is $0.21.
Mach7 Technologies share price increased by 15.1% in the last 30 days, and decreased by 20.5% in the last year.
Mach7 Technologies has an EPS (earnings per share) of $-0.02.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $37M | $49M | 4.9% | 15.1% | -13.0% | -20.5% | $-0.02 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialMach7 Technologies Valuation Multiples
Mach7 Technologies trades at 1.9x EV/Revenue multiple, and (14.4x) EV/EBITDA.
EV / Revenue (LTM)
Mach7 Technologies Financial Valuation Multiples
As of May 16, 2026, Mach7 Technologies has market cap of $49M and EV of $37M.
Mach7 Technologies has a P/E ratio of (7.6x).
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Mach7 Technologies Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


Mach7 Technologies Margins & Growth Rates
Mach7 Technologies grew revenue by 22% and EBITDA by 135% in the last fiscal year.
In the most recent fiscal year, Mach7 Technologies reported gross margin of 82%, EBITDA margin of (7%), and net margin of (25%).
Mach7 Technologies Margins
Mach7 Technologies Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
Mach7 Technologies Operational KPIs
Mach7 Technologies' revenue per employee in the last FY averaged $0.2M, while opex per employee averaged $0.3M for the same period.
Mach7 Technologies' Rule of 40 is 9% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Mach7 Technologies' Rule of X is 38% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Data powered by FactSet, Inc. and Morningstar, Inc.
Mach7 Technologies Competitors
Mach7 Technologies competitors include BIT Computer, MeVis, 111, Deepnoid, Data Horizon, PharmX Technologies, INIFY Laboratories, MDxHealth, SOFTMAX and Mentice.
Most Mach7 Technologies public comparables operate across Healthcare Software, Medical Imaging & Diagnostics, B2B SaaS, Vertical SaaS and HealthTech.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| 1.2x | β | 4.3x | β | |||
| 2.3x | β | 10.6x | β | |||
| 0.0x | β | 0.9x | β | |||
| 7.1x | β | (5.6x) | β | |||
| 2.7x | β | (4.4x) | β | |||
| 9.6x | β | 50.5x | β | |||
| 18.8x | β | (6.6x) | β | |||
| 1.0x | 0.9x | (79.6x) | (25.7x) | |||
This data is available for Pro users. Sign up to see all Mach7 Technologies competitors and their valuation data. Start Free Trial | ||||||
Mach7 Technologies M&A Activity
Mach7 Technologies has acquired 2 companies to date.
Last acquisition by Mach7 Technologies was on June 10th 2020. Mach7 Technologies acquired Client Outlook for $27M (EV/Revenue multiple of ).
Latest Acquisitions by Mach7 Technologies
| Description | Client Outlook is a Pittsburgh-headquartered healthcare technology provider focusing on secure communication tools for physicians and nurses. Established in 2011, it develops mobile apps for patient handoffs, secure messaging, and workflow coordination compatible with EHRs like Allscripts and athenahealth. Deployed in over 200 U.S. hospitals, the platform complies with HIPAA standards, reducing communication errors in emergency departments and ICUs across Pennsylvania and neighboring states. | 3D Medical is an Australian medical technology firm specializing in 3D printing and advanced visualization solutions for healthcare applications. The company provides patient-specific anatomical models for surgical planning, diagnostic support, and medical education. Services include holographic projection technology through EchoPixel partnership, gesture-controlled in-surgery image manipulation via GestSure integration, and enterprise imaging data management through Mach 7 systems. Focused on improving clinical outcomes through advanced visualization and physical modeling of patient anatomy. |
| HQ Country | ||
| HQ City | Waterloo | β |
| Deal Date | 10 Jun 2020 | 8 Apr 2016 |
| Valuation | $27M | $60M |
| EV/Revenue | ||
| EV/EBITDA | ||
This data is available for Pro users. Sign up to see all Mach7 Technologies acquisitions and their M&A valuation multiples. Start Free Trial | ||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Mach7 Technologies
| When was Mach7 Technologies founded? | Mach7 Technologies was founded in 1977. |
| Where is Mach7 Technologies headquartered? | Mach7 Technologies is headquartered in United States. |
| How many employees does Mach7 Technologies have? | As of today, Mach7 Technologies has over 103 employees. |
| Is Mach7 Technologies publicly listed? | Yes, Mach7 Technologies is a public company listed on Australian Securities Exchange. |
| What is the stock symbol of Mach7 Technologies? | Mach7 Technologies trades under M7T ticker. |
| When did Mach7 Technologies go public? | Mach7 Technologies went public in 2005. |
| Who are competitors of Mach7 Technologies? | Mach7 Technologies main competitors include BIT Computer, MeVis, 111, Deepnoid, Data Horizon, PharmX Technologies, INIFY Laboratories, MDxHealth, SOFTMAX, Mentice. |
| What is the current market cap of Mach7 Technologies? | Mach7 Technologies' current market cap is $49M. |
| What is the current revenue of Mach7 Technologies? | Mach7 Technologies' last 12 months revenue is $20M. |
| What is the current revenue growth of Mach7 Technologies? | Mach7 Technologies revenue growth (NTM/LTM) is 10%. |
| What is the current EV/Revenue multiple of Mach7 Technologies? | Current revenue multiple of Mach7 Technologies is 1.9x. |
| Is Mach7 Technologies profitable? | No, Mach7 Technologies is not profitable. |
| What is the current EBITDA of Mach7 Technologies? | Mach7 Technologies has negative EBITDA and is not profitable. |
| What is Mach7 Technologies' EBITDA margin? | Mach7 Technologies' last 12 months EBITDA margin is (13%). |
| What is the current EV/EBITDA multiple of Mach7 Technologies? | Current EBITDA multiple of Mach7 Technologies is (14.4x). |
| What is the current FCF of Mach7 Technologies? | Mach7 Technologies' last 12 months FCF is ($3M). |
| What is Mach7 Technologies' FCF margin? | Mach7 Technologies' last 12 months FCF margin is (14%). |
| What is the current EV/FCF multiple of Mach7 Technologies? | Current FCF multiple of Mach7 Technologies is (13.4x). |
| How many companies Mach7 Technologies has acquired to date? | As of May 2026, Mach7 Technologies has acquired 2 companies. |
| What was the largest acquisition by Mach7 Technologies? | $60M acquisition of 3D Medical on 8th April 2016 was the largest M&A Mach7 Technologies has done to date. |
| What companies Mach7 Technologies acquired? | Mach7 Technologies acquired 3D Medical and Client Outlook. |
| In how many companies Mach7 Technologies has invested to date? | Mach7 Technologies hasn't invested in any companies yet (or none have been disclosed publicly). |
See public comps similar to Mach7 Technologies
Lists including Mach7 Technologies
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

